Grime, Dust and Duct Tape Found at J&J Plant

U.S. inspectors who toured the Johnson & Johnson plant at the center of last week's recall of widely used liquid children's products uncovered unsanitary conditions in at least one lab, according to a government report released on Tuesday.

The U.S. Food and Drug Administration (FDA) said in the report, dated April 30, that its inspectors found thick dust and grime covering certain equipment, a hole in the ceiling and duct tape-covered pipes at the Fort Washington, Penn., facility where 40 products recalled last Friday were made. Inspectors also found a lack of quality control procedures and poor handling of complaints, according to the report.

On Saturday, the FDA urged consumers to stop using liquid Tylenol, Motrin, Benadryl and Zyrtec for children and infants after a broad recall by Johnson & Johnson's consumer division late on Friday. Read the full list of more than 40 affected products made by McNeil Consumer Healthcare here.

McNeil said it was recalling the products in consultation with the FDA after discovering manufacturing deficiencies that could affect the quality, purity or potency of the medicines. On Tuesday, the FDA posted the inspection notice.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.